Warfarin-related nephropathy: Possible role for the warfarin pharmacogenetic profile

Clinical Kidney Journal

Volumn 7, Issue 6, 2014, Pages

  Di Maso, Vittorio ^a   Carraro, Michele ^a,b   Bevilacqua, Elena ^a   Bucconi, Sergio ^a   Artero, Mary Louise ^a   Boscutti, Giuliano ^a  

^a AOTS   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

acute kidney injury; chronic kidney disease; corticosteroids; warfarin pharmacogenetics; warfarin related nephropathy

Indexed keywords

BENCE JONES PROTEIN; BICARBONATE; BISOPROLOL; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PANTOPRAZOLE; PREDNISONE; SERUM ALBUMIN; WARFARIN;

AGED; ANOREXIA; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPEPSIA; GENE FREQUENCY; GENERAL CONDITION DETERIORATION; GENETIC ANALYSIS; GLOMERULOSCLEROSIS; HEMATURIA; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MALE; NOCTURIA; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TREATMENT REFUSAL; TUBULAR DYSFUNCTION; URINALYSIS; WARFARIN RELATED NEPHROPATHY; WEIGHT REDUCTION; WILD TYPE;

EID: 84928490145     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfu112     Document Type: Article

References (15)

1. Rubboli A, Becattini C, Verheugt FW. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol 2011; 3: 351-358
2. Brodsky SV, Satoskar A, Chen J et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 2009; 54: 1121-1126
3. Brodsky SV, Nadasdy T, Rovin BH et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 2011; 80: 181-189
4. Brodsky SV, Collins M, Park E et al. Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 2010; 115: c142-c146
5. Johnson JA, Gong L, Whirl-Carrillo M et al., (Implementation Consortium Clinical Pharmacogenetics). Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 2011; 90: 625-629
6. Schwarz UI, Ritchie MD, Bradford Y et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008; 358: 999-1008
7. Kimmel SE, French B, Kasner SE et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 2013; 369: 2283-2293
8. Abt AB, Carroll LE, Mohler JH. Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis. Am J Kidney Dis 2000; 35: 533-536
9. An JN, Ahn SY, Yoon CH et al. The occurrence of warfarinrelated nephropathy and effects on renal and patient outcomes in Korean patients. PLoS One 2013; 8: e57661
10. Logan I, Sheerin NS. Anticoagulation and kidney injury: rare observation or common problem? J Nephrol 2013; 26: 603-605
11. Ozcan A, Ware K, Calomeni E et al. 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 2012; 35: 356-364
12. Ware K, Brodsky P, Satoskar AA et al. Warfarin related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 2011; 22: 1856-1862
13. Moreno JA, Martín-Cleary C, Gutiérrez E et al. AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J AmSoc Nephrol 2012; 7: 175-184
14. Limdi NA, Beasley TM, Baird MF et al. Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 2009; 20: 912-921
15. Yang J, Chen Y, Li X et al. Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and metaanalysis. Int J Cardiol 2013; 168: 4234-4243